AgingResearch.News
AHA Scientific Sessions 2025 Abstract

Vutrisiran Improved Outcomes Versus Placebo in Patients with Transthyretin Amyloidosis with Cardiomyopathy and Severe Chronic Kidney Disease: Post Hoc Analysis of HELIOS-B

By Farooq H. Sheikh, Julien Dang, Marianna Fontana, Show 8 more authorsAli Yilmaz
Trial in peopleInterventions
Paper

The paper

Farooq H. Sheikh, Julien Dang, Marianna Fontana, Show 8 more authorsAli Yilmaz

Georgetown University; University Hospital Münster

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4362795

doi.org/10.1161/circ.152.suppl_3.4362795

Related